PEN Logo

Penumbra Inc (PEN) Stock Forecast & Price Prediction

Live PEN Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Devices

$265.94

+3.83 (1.46%)

12 Month Price Forecast For PEN

$265.94
Current Price
$10.06B
Market Cap
18 Ratings
Buy 14
Hold 4
Sell 0
Wall St Analyst Ratings

Distance to PEN Price Forecasts

+21.5%
To High Target of $323.00
+0.0%
To Median Target of $266.00
-13.5%
To Low Target of $230.00

PEN Price Momentum

-1.1%
1 Week Change
+12.1%
1 Month Change
+2.8%
1 Year Change
+12.0%
Year-to-Date Change
-4.3%
From 52W High of $277.89
+79.7%
From 52W Low of $148.00

๐Ÿค” Considering Penumbra (PEN)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 6, 2025 5:30 AM UTC

PEN Analyst Ratings & Price Targets

Based on our analysis of 19 Wall Street analysts, PEN has a consensus that is bullish. The median price target is $266.00, with forecasts ranging from $230.00 to $323.00. Currently, there are 14 Buy ratings, 4 Hold ratings, and 0 Sell ratings.

With PEN currently trading at $265.94, the median price forecast suggests a 0.0% upside. The most optimistic forecast comes from Jason Mills at Canaccord Genuity, projecting a 21.5% upside, while Richard Newitter at Truist Securities provides the most conservative target, suggesting a -13.5% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

PEN Analyst Consensus

14
Buy
4
Hold
0
Sell

PEN Price Target Range

Low
$230.00
Average
$266.00
High
$323.00
Current: $265.94

Latest PEN Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for PEN.

Date Firm Analyst Rating Change Price Target
Jan 23, 2025 Baird David Rescott Outperform Maintains $305.00
Jan 21, 2025 UBS Priya Sachdeva Buy Initiates $305.00
Dec 18, 2024 Truist Securities Richard Newitter Buy Maintains $285.00
Dec 17, 2024 Oppenheimer Steve Lichtman Outperform Initiates $275.00
Dec 11, 2024 Wells Fargo Larry Biegelsen Overweight Upgrade $275.00
Dec 11, 2024 Citigroup Joanne Wuensch Neutral Maintains $245.00
Dec 9, 2024 Canaccord Genuity Jason Mills Buy Maintains $323.00
Dec 2, 2024 Morgan Stanley Equal-Weight Maintains $0.00
Nov 26, 2024 BTIG Ryan Zimmerman Buy Maintains $270.00
Nov 20, 2024 Piper Sandler Matt O'Brien Overweight Maintains $250.00
Nov 4, 2024 Canaccord Genuity Buy Maintains $0.00
Oct 31, 2024 Piper Sandler Matt O'Brien Overweight Maintains $235.00
Oct 31, 2024 Needham Mike Matson Hold Reiterates $0.00
Oct 31, 2024 Baird David Rescott Outperform Maintains $248.00
Oct 31, 2024 BTIG Buy Maintains $0.00
Oct 25, 2024 Needham Mike Matson Hold Reiterates $0.00
Oct 18, 2024 Piper Sandler Matt O'Brien Overweight Reiterates $225.00
Oct 16, 2024 Canaccord Genuity Jason Mills Buy Maintains $235.00
Oct 15, 2024 Baird Outperform Maintains $0.00
Oct 14, 2024 BTIG Ryan Zimmerman Buy Maintains $234.00

Stocks Similar to Penumbra Inc

The following stocks are similar to Penumbra based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Penumbra Inc (PEN) Financial Data

Penumbra Inc has a market capitalization of $10.06B with a P/E ratio of 301.3x. The company generates $1.16B in trailing twelve-month revenue with a 3.0% profit margin.

Revenue growth is +11.1% quarter-over-quarter, while maintaining an operating margin of +11.7% and return on equity of +3.1%.

Valuation Metrics

Market Cap $10.06B
Enterprise Value $10.11B
P/E Ratio 301.3x
PEG Ratio 69.3x
Price/Sales 8.6x

Growth & Margins

Revenue Growth (YoY) +11.1%
Gross Margin +66.5%
Operating Margin +11.7%
Net Margin +3.0%
EPS Growth +220.5%

Financial Health

Cash/Price Ratio +2.9%
Current Ratio 5.8x
Debt/Equity 20.5x
ROE +3.1%
ROA +3.3%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Penumbra Inc logo

Penumbra Inc (PEN) Company Overview

About Penumbra Inc

What They Do

Develops and markets medical devices globally.

Business Model

The company generates revenue by designing, manufacturing, and selling a wide range of medical devices, primarily used for vascular interventions and neurovascular treatments. Its products include thrombectomy systems, access devices, and embolization solutions, which are sold through direct sales and distribution channels in both domestic and international markets.

Additional Information

Founded in 2004 and headquartered in Alameda, California, Penumbra, Inc. focuses on innovation in medical technology. The companyโ€™s product portfolio addresses critical medical needs in peripheral and neurovascular applications, positioning it well within the growing healthcare sector.

Company Information

Sector

Healthcare

Industry

Medical Devices

Employees

4,200

CEO

Mr. Adam Elsesser J.D.

Country

United States

IPO Year

2015

Penumbra Inc (PEN) Latest News & Analysis

PEN stock latest news image
Quick Summary

Penumbra, Inc. (NYSE: PEN) will hold a conference call on February 18, 2025, at 4:30 PM ET to discuss its Q4 and full year 2024 financial results.

Why It Matters

Penumbra's upcoming earnings call may impact stock performance, providing insights into financial health and growth prospects that influence investor sentiment and decision-making.

Source: PRNewsWire
Market Sentiment: Neutral
PEN stock latest news image
Quick Summary

Penumbra (PEN) shows above-average growth in financials, indicating a strong market position and potential for outperformance.

Why It Matters

Penumbra's above-average financial growth suggests strong future performance, potentially leading to increased stock value and attracting more investment interest.

Source: Zacks Investment Research
Market Sentiment: Positive
PEN stock latest news image
Quick Summary

Consider investing in YPF, TEF, PEN, DECK, and ANF to capitalize on their increased efficiency levels.

Why It Matters

Higher efficiency levels in companies like YPF, TEF, PEN, DECK, and ANF can lead to improved profitability, making them attractive investment opportunities for potential growth.

Source: Zacks Investment Research
Market Sentiment: Positive
PEN stock latest news image
Quick Summary

Investors are advised to focus on low-beta stocks to manage market volatility, with AVO, TXO, PEN, and STRA identified as strong options.

Why It Matters

Low-beta stocks like AVO, TXO, PEN, and STRA can provide stability and potential gains during market volatility, appealing to risk-averse investors seeking to preserve capital.

Source: Zacks Investment Research
Market Sentiment: Positive
PEN stock latest news image
Quick Summary

PEN is attracting investor attention due to its robust Thrombectomy business and strategic plans for international expansion.

Why It Matters

PEN's robust Thrombectomy segment and expansion into international markets signal potential revenue growth, making it an attractive opportunity for investors seeking strong performance.

Source: Zacks Investment Research
Market Sentiment: Neutral
PEN stock latest news image
Quick Summary

Penumbra (PEN) shares surged recently, with above-average trading volume, but earnings estimate revisions may not lead to further price increases soon.

Why It Matters

Penumbra's share surge and high trading volume indicate strong investor interest, but revised earnings estimates may signal potential volatility or a plateau in price growth.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About PEN Stock

What is Penumbra Inc's (PEN) stock forecast for 2025?

Based on our analysis of 19 Wall Street analysts, Penumbra Inc (PEN) has a median price target of $266.00. The highest price target is $323.00 and the lowest is $230.00.

Is PEN stock a good investment in 2025?

According to current analyst ratings, PEN has 14 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $265.94. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for PEN stock?

Wall Street analysts predict PEN stock could reach $266.00 in the next 12 months. This represents a 0.0% increase from the current price of $265.94. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Penumbra Inc's business model?

The company generates revenue by designing, manufacturing, and selling a wide range of medical devices, primarily used for vascular interventions and neurovascular treatments. Its products include thrombectomy systems, access devices, and embolization solutions, which are sold through direct sales and distribution channels in both domestic and international markets.

What is the highest forecasted price for PEN Penumbra Inc?

The highest price target for PEN is $323.00 from Jason Mills at Canaccord Genuity, which represents a 21.5% increase from the current price of $265.94.

What is the lowest forecasted price for PEN Penumbra Inc?

The lowest price target for PEN is $230.00 from Richard Newitter at Truist Securities, which represents a -13.5% decrease from the current price of $265.94.

What is the overall PEN consensus from analysts for Penumbra Inc?

The overall analyst consensus for PEN is bullish. Out of 19 Wall Street analysts, 14 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $266.00.

How accurate are PEN stock price projections?

Stock price projections, including those for Penumbra Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.